Published in J Biol Chem on December 05, 2000
Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites. Clin Microbiol Rev (2007) 1.45
A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. J Exp Med (2002) 1.41
PLP-dependent H(2)S biogenesis. Biochim Biophys Acta (2011) 1.29
Modulation of the heme electronic structure and cystathionine beta-synthase activity by second coordination sphere ligands: The role of heme ligand switching in redox regulation. J Inorg Biochem (2009) 1.22
Conversion of methionine to cysteine in Bacillus subtilis and its regulation. J Bacteriol (2006) 1.14
Sulfur amino acid metabolism and its control in Lactococcus lactis IL1403. J Bacteriol (2005) 1.13
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis (2012) 1.11
Aerobic kinetoplastid flagellate Phytomonas does not require heme for viability. Proc Natl Acad Sci U S A (2012) 1.04
Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J Biol Chem (2008) 1.03
Purification and characterization of the wild type and truncated human cystathionine beta-synthase enzymes expressed in E. coli. Arch Biochem Biophys (2007) 1.01
Heme regulation of human cystathionine beta-synthase activity: insights from fluorescence and Raman spectroscopy. J Am Chem Soc (2009) 0.98
Characterization of a novel thermostable O-acetylserine sulfhydrylase from Aeropyrum pernix K1. J Bacteriol (2003) 0.91
Novel structural arrangement of nematode cystathionine β-synthases: characterization of Caenorhabditis elegans CBS-1. Biochem J (2012) 0.89
Kinetics of reversible reductive carbonylation of heme in human cystathionine β-synthase. Biochemistry (2013) 0.85
Cobalt cystathionine β-synthase: a cobalt-substituted heme protein with a unique thiolate ligation motif. Inorg Chem (2011) 0.84
Domain organization, catalysis and regulation of eukaryotic cystathionine beta-synthases. PLoS One (2014) 0.82
Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine β-synthase. Biochemistry (2012) 0.81
Purification, crystallization and preliminary crystallographic analysis of human cystathionine β-synthase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.80
Transsulfuration is an active pathway for cysteine biosynthesis in Trypanosoma rangeli. Parasit Vectors (2014) 0.78
Upregulation of Cysteine Synthase and Cystathionine β-Synthase Contributes to Leishmania braziliensis Survival under Oxidative Stress. Antimicrob Agents Chemother (2015) 0.77
Purification, crystallization and preliminary crystallographic analysis of the full-length cystathionine β-synthase from Apis mellifera. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.77
Purification, crystallization and preliminary crystallographic analysis of the catalytic core of cystathionine β-synthase from Saccharomyces cerevisiae. Acta Crystallogr F Struct Biol Commun (2014) 0.75
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med (1998) 3.81
Cystathionine beta-synthase mutations in homocystinuria. Hum Mutat (1999) 1.96
Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol (1995) 1.80
Evidence for heme-mediated redox regulation of human cystathionine beta-synthase activity. J Biol Chem (1998) 1.74
Characteristics and surgical outcomes of paediatric retinal detachment. Eye (Lond) (2004) 1.66
Structure and content of the Entamoeba histolytica genome. Adv Parasitol (2007) 1.62
Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis. Hum Mol Genet (2001) 1.59
Correction of disease-causing CBS mutations in yeast. Nat Genet (1998) 1.55
Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone. Diabet Med (1996) 1.42
Polarization mode control of two-dimensional photonic crystal laser by unit cell structure design. Science (2001) 1.39
The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med (2001) 1.35
Alteration of insulin-receptor kinase activity by high-fat feeding. Diabetes (1988) 1.29
Sequences expressed sex-specifically in Drosophila melanogaster adults. Dev Biol (1987) 1.28
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care (2001) 1.24
Phosphorylation of carnitine palmitoyltransferase and activation by glucagon in isolated rat hepatocytes. FEBS Lett (1985) 1.24
Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet (1996) 1.23
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol (1997) 1.18
Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr Alzheimer Res (2010) 1.18
Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol (1990) 1.18
Clonal sublines of rat neurotumor RT4 and cell differentiation. I. Isolation and characterization of cell lines and cell type conversion. Dev Biol (1978) 1.16
Ab initio studies on the interplay between spin-orbit interaction and Coulomb correlation in Sr2IrO4 and Ba2IrO4. Phys Rev Lett (2012) 1.13
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul (1999) 1.10
Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth. Cancer Res (2000) 1.09
Regulatory mechanism of ketogenesis by glucagon and insulin in isolated and cultured hepatocytes. J Biochem (1982) 1.07
Ethanol patch test--a simple and sensitive method for identifying ALDH phenotype. Alcohol Clin Exp Res (1989) 1.03
Functional characterization of human methylenetetrahydrofolate reductase in Saccharomyces cerevisiae. J Biol Chem (1999) 1.01
Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab (1977) 1.01
Evaluation of the method of insulin binding studies in human erythrocytes. Endocrinol Jpn (1980) 1.00
Semisynthesis and properties of some insulin analogs. Biopolymers (1981) 1.00
Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J Diabetes Complications (1995) 0.99
Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol (1996) 0.99
Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response. Hum Mutat (2006) 0.99
Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. J Diabetes Complications (1996) 0.98
Long-term in vitro effects of insulin on insulin binding and glucose transport. Diabetes Res Clin Pract (1986) 0.98
A survey for Yersinia pseudotuberculosis in migratory birds in coastal Japan. J Wildl Dis (1989) 0.98
Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. Biochem J (1982) 0.96
Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int (1991) 0.96
Clonal sublines of rat neurotumor RT4 and cell differentiation. II. A conversion coupling of tumorigenicity and a glial property. Dev Biol (1978) 0.96
Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia (1991) 0.95
Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes (1991) 0.95
Frameshift mutation in the lysozyme gene of bacteriophage T4: demonstration of the insertion offour bases and the preferential occurrence of base addition in acridine mutagenesis. J Mol Biol (1970) 0.94
Effect of diet change on insulin action: difference between muscles and adipocytes. Am J Physiol (1986) 0.94
High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts. Biochem Biophys Res Commun (1994) 0.94
Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance. Diabetologia (1989) 0.94
Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes (1992) 0.93
Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235. Diabetes (1989) 0.93
Traumatic dislocation of the mandibular condyle into the temporal fossa in a child. J Trauma (2000) 0.92
Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia (1994) 0.92
Fetomodulin: marker surface protein of fetal development which is modulatable by cyclic AMP. Dev Biol (1987) 0.92
Anatomical analysis of the human lacrimal drainage pathway under an operating microscope. Int Ophthalmol (1991) 0.92
Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther (1984) 0.92
Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin. Experientia (1981) 0.91
A morphological study of age changes in adult human auricular cartilage with special emphasis on elastic fibers. Laryngoscope (2001) 0.91
Reduced nasal nitric oxide in diffuse panbronchiolitis. Am J Respir Crit Care Med (2000) 0.90
Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism (1990) 0.90
Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium. Diabetes (1995) 0.90
Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem (1995) 0.89
Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care (1996) 0.89
Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats. Diabetes (1991) 0.89
Spinal cord compression with paraplegia in xanthomatosis due to normocholesterolemic sitosterolemia. Ann Neurol (1990) 0.89
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II). Amino Acids (2003) 0.88
Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia (1994) 0.88
Insulin resistance by uncleaved insulin proreceptor. Emergence of binding site by trypsin. Diabetes (1988) 0.88
Macroscopic intestinal colonies of mice as a tool for studying differentiation of multipotential intestinal stem cells. Am J Pathol (1988) 0.88
Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer (2001) 0.88
Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol (1999) 0.88
Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes (1988) 0.87
Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study. Diabetes Care (1988) 0.87
Alcohol dehydrogenase: a new sensitive marker of hepatic centrilobular damage. Alcohol (1985) 0.87
Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism (1996) 0.87
The amino acid sequence of T4 phage lysozyme. IV. Dilute acid hydrolysis and the order of tryptic peptides. J Biol Chem (1970) 0.86
A primary defect in insulin receptor in a young male patient with insulin resistance. Metabolism (1986) 0.86
Ethanol metabolism in vivo by the microsomal ethanol-oxidizing system in deermice lacking alcohol dehydrogenase (ADH). Biochem Pharmacol (1984) 0.86
Hepatic and intestinal gamma-glutamyltranspeptidase activity: its activation by chronic ethanol administration. Life Sci (1978) 0.86
Atrial natriuretic peptide inhibits endothelin-1-induced activation of mitogen-activated protein kinase in cultured rat mesangial cells. Biochem Biophys Res Commun (1993) 0.86
Insulin resistance by unprocessed insulin proreceptors point mutation at the cleavage site. Biochem Biophys Res Commun (1988) 0.85
Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin. Biochem Biophys Res Commun (1984) 0.85
A two-dimensional polyacrylamide gel electrophoresis system for the analysis of mammalian cell surface proteins. Biochim Biophys Acta (1980) 0.85
Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study. Biomed Pharmacother (1995) 0.85
Tolrestat improves nerve regeneration after crush injury in streptozocin-induced diabetic rats. Metabolism (1996) 0.84
Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors. Biochem Biophys Res Commun (1982) 0.84
Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism (1978) 0.84
Application of rapid freezing followed by freeze-substitution acrolein fixation for cytochemical studies of the rat stomach. Histochem J (1985) 0.84
Immunoreactivity and biologic activity of semisynthetic [LeuB-30]-insulin: potential value in the treatment of insulin antibody-mediated insulin resistance. Diabetes (1981) 0.84
Fibronectin phosphorylation by ecto-protein kinase. Exp Cell Res (1988) 0.83
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat. Diabet Med (2008) 0.83
Fluctuation of insulin resistance in a leprechaun with a primary defect in insulin binding. J Clin Endocrinol Metab (1988) 0.83
Forensic study of sex determination using PCR on teeth samples. Acta Med Okayama (2000) 0.83
Clarification of signaling pathways mediated by insulin and insulin-like growth factor I receptors in fibroblasts from patients with specific defect in insulin receptor. Diabetes (1988) 0.83
Familial spinal xanthomatosis with sitosterolemia. Intern Med (1992) 0.83
HLA antigens as immunogenetic markers of alcoholism and alcoholic liver disease. Pharmacol Biochem Behav (1980) 0.83
Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology. Diabetes Res Clin Pract (1989) 0.83
Characterization of a human rhabdomyosarcoma cell strain in tissue culture. Biomed Pharmacother (1985) 0.83
Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes (1987) 0.82
Transfection of cDNA with G----T point mutation at the cleavage site of insulin receptors to COS 7 cells. Biochem Biophys Res Commun (1990) 0.82
Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve. Horm Metab Res (1988) 0.82
A case of obstructive sleep apnoea with anterior cervical osteophytes. J Oral Rehabil (2009) 0.82
Visibility and aerosol concentration in urban air. Atmos Environ (1968) 0.82